CTNNB1 and neoplasm: Tumours from KrasG12D-primed mice showed the smallest range of O/E ratios; combined with the high tumour multiplicity observed in these mice, this finding indicates that expression of KrasG12D creates a broadly permissive transformation landscape for Ctnnb1-activating mutations.